Literature DB >> 12429553

Role of macula densa cyclooxygenase-2 in renovascular hypertension.

Andrea Hartner1, Nada Cordasic, Margarete Goppelt-Struebe, Roland Veelken, Karl F Hilgers.   

Abstract

Upregulation of the inducible cyclooxygenase (COX-2) in the macula densa accompanies the activation of the juxtaglomerular apparatus in many high-renin conditions. The functional role of COX-2 in these disease states is poorly understood. We tested whether COX-2 is required to increase renin in renovascular hypertension. Rats with established two-kidney, one-clip (2K1C) hypertension were treated for 2 wk with two different inhibitors of COX-2, NS-398 and rofecoxib, respectively. Hypertension in 2K1C rats was not affected or slightly enhanced by COX-2 inhibition, as measured intra-arterially in conscious animals. The increase in plasma renin activity was also unchanged by both rofecoxib and NS-398. The number of glomeruli with a renin-positive juxtaglomerular apparatus was elevated in clipped kidneys and decreased in contralateral kidneys of 2K1C rats. This pattern was unaltered by COX-2 inhibition. To test the effects of COX-2 blockade on a primarily macula densa-mediated stimulus, we studied salt depletion for comparison. A low-salt diet induced a significant increase in plasma renin activity, which was partially inhibited by treatment with NS-398. We conclude that inhibition of COX-2 in established renovascular hypertension does not affect renin synthesis or release. Thus either COX-2 is not necessary for the macula densa mechanism or the macula densa is not important for maintaining high renin in renovascular hypertension.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429553     DOI: 10.1152/ajprenal.00136.2002

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

Review 1.  Tubular control of renin synthesis and secretion.

Authors:  Jurgen Schnermann; Josephine P Briggs
Journal:  Pflugers Arch       Date:  2012-06-05       Impact factor: 3.657

2.  An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.

Authors:  John D Imig; Xueying Zhao; Constantine Z Zaharis; Jeffrey J Olearczyk; David M Pollock; John W Newman; In-Hae Kim; Takaho Watanabe; Bruce D Hammock
Journal:  Hypertension       Date:  2005-09-12       Impact factor: 10.190

Review 3.  Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?

Authors:  Irmgard Tegeder; Gerd Geisslinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-04       Impact factor: 3.000

4.  Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide.

Authors:  Magali Araujo; William J Welch
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

5.  Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP.

Authors:  Takayuki Fujino; Naoki Nakagawa; Koh-Ichi Yuhki; Akiyoshi Hara; Takehiro Yamada; Koji Takayama; Shuhko Kuriyama; Yayoi Hosoki; Osamu Takahata; Takanobu Taniguchi; Jun Fukuzawa; Naoyuki Hasebe; Kenjiro Kikuchi; Shuh Narumiya; Fumitaka Ushikubi
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

6.  Demethoxycurcumin Preserves Renovascular Function by Downregulating COX-2 Expression in Hypertension.

Authors:  Yingjuan Li; Danyang Tian; Chunhua Zhu; Liqun Ren
Journal:  Oxid Med Cell Longev       Date:  2016-12-25       Impact factor: 6.543

7.  Responsiveness of afferent renal nerve units in renovascular hypertension in rats.

Authors:  Kristina Rodionova; Karl F Hilgers; Salman Rafii-Tabrizi; Johannes Doellner; Nada Cordasic; Peter Linz; Anna-Lena Karl; Christian Ott; Roland E Schmieder; Mario Schiffer; Kerstin Amann; Roland Veelken; Tilmann Ditting
Journal:  Pflugers Arch       Date:  2021-07-07       Impact factor: 3.657

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.